GT Biopharma, Inc. (GTBP)
0.4623
0.00 (0.00%)
USD |
NASDAQ |
Mar 23, 14:32
GT Biopharma EPS Diluted (Quarterly) : -4.413 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| SELLAS Life Sciences Group, Inc. | -0.05 |
| Lyell Immunopharma, Inc. | -6.622 |
| ACADIA Pharmaceuticals, Inc. | 1.596 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
| Savara, Inc. | -0.1341 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -23.03M |
| Total Expenses (Quarterly) | 23.03M |
| Enterprise Value | 7.614M |
| Earnings Yield | -3.16K% |
| Normalized Earnings Yield | -3939.95 |